Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 29, 2014Nephron Clinical Practice

Rituximab in Systemic Lupus Erythematosus and Lupus Nephritis

View Full Paper
Ask AI
Bookmark
Share

Authors

HBHannah BeckwithKing's College - North CarolinaLLLiz LightstoneUniversity of London

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Beckwith et al. (2014) studied this question.

synapsesocial.com/papers/6a0166672ff633f3657868cfhttps://doi.org/10.1159/000368585
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1B Lymphocytes: Development, Tolerance, and Their Role in Autoimmunity—Focus on Systemic Lupus Erythematosus2013 · 95 citations
  2. 2Assessment of a lupus nephritis cohort over a 30-year period2011 · 178 citations
  3. 3Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study2011 · 88 citations
  4. 4Beyond immunosuppression – challenges in the clinical management of lupus nephritis2009 · 28 citations
  5. 5Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids2009 · 156 citations